Grimaud, E., Soubigou, L., Couillaud, S., Coipeau, P., Moreau, A., Passuti, N., . . . Heymann, D. (2003). Receptor Activator of Nuclear Factor κB Ligand (RANKL)/Osteoprotegerin (OPG) Ratio Is Increased in Severe Osteolysis. American Society for Investigative Pathology.
Chicago Style aipamenaGrimaud, Eva, Luc Soubigou, Séverine Couillaud, Patrick Coipeau, Anne Moreau, Norbert Passuti, François Gouin, Françoise Redini, and Dominique Heymann. Receptor Activator of Nuclear Factor κB Ligand (RANKL)/Osteoprotegerin (OPG) Ratio Is Increased in Severe Osteolysis. American Society for Investigative Pathology, 2003.
MLA aipamenaGrimaud, Eva, et al. Receptor Activator of Nuclear Factor κB Ligand (RANKL)/Osteoprotegerin (OPG) Ratio Is Increased in Severe Osteolysis. American Society for Investigative Pathology, 2003.